Time Magazine’s year-end “Person of the Year” special issue features the scientists behind CRISPR including ACGT Research Fellow, Dr. Carl June. This amazing medical breakthrough as described in the ACGT blog, may help prove the end to cancer. Dr. Carl June is preparing to launch his most
ambitious study yet at University of Pennsylvania: to treat 18 people with stubborn cancers, using CRISPR. June’s team will extract their T cells, a kind of immune cell, and use CRISPR to alter three genes in those cells. The patients will then be reinfused with the cancer-fighting T cells to test if tumors are destroyed. Studies like June’s may lead to the development of new, smarter treatments. Read more.